Deleterious off-target effects in women 10 years or more past menopause, such as ovarian, endometrial, and breast cancers, intravascular thrombosis, cardiovascular episodes, and stroke, and suppression of endogenous testosterone and libido and increased risk of prostate cancer in men, have precluded broad clinical applications (Hall and Phillips, 2005
The higher dose of ALC was non-significantly more effective than placebo
Weight-loss outcomes supported by peer-reviewed clinical data Naturally helps curb appetite and minimize unnecessary snacking Encourages a more efficient metabolism and consistent daily energy Supports healthier insulin function and more stable blood-sugar patterns Promotes lasting fullness to help reduce overeating GLP-1s work with your body's natural biology to support meaningful, sustainable weight loss
PMID 27138887
Integrated Research Applications GLP-1S is used in research to examine incretin biology, receptor signaling, and metabolic control
This contribute to a feeling of fullness and reduce the rate at which nutrients are absorbed, helping to control eating behaviors and reduce calorie intake